'Shocking' differences in costs of drug prices across the world

clock • 1 min read

There are large disparities in prescription and speciality drug prices across Western countries according to research from International Federation of Health Plans (iFHP.)

Prescription pain medication, OxyContin, costs the equivalent of $36 in Spain, but jumps to an average cost of $265 in the United States and the equivalent of $590 in the United Kingdom.

Tom Sackville, chief executive of the iFHP said: "We look at these numbers every year and it's always a shocking demonstration of how much procedures and prescription drugs actually cost."

The figures come from the iFHP's 2015 Comparative Price Report, an annual survey of medical prices per unit. The report examined the price of medical procedures, tests, scans and treatments in seven countries.

The report revealed that other known drugs such as Truvada, prescribed for treating HIV/AIDS, cost less than the equivalent of $1,000 in Spain, United Kingdom and Switzerland, but cost an average $1,290 in the United States.

Similarly, Humira, a drug prescribed for rheumatoid arthritis has prices ranging from $552 in South Africa to an average $2,669 in the United States.

Meanwhile the US had the highest hospital cost per day of $5,220 with Spain having the lowest hospital cost per day of $424.

Prices for Australia, New Zealand, Spain, South Africa, Switzerland and the UK in the report come from the private sector, with data provided by one private health plan in each country.
Prices for the United States were derived from over 370 million medical claims and over 170 million pharmacy claims that reflect prices negotiated and paid to health care providers.
Sackville added: "There is no reason why identical procedures and products should vary in price so much across countries: it illustrates the damaging effects of an inadequately regulated healthcare market."

More on PMI

Private healthcare invoices slow in 2025: Healthcode
PMI

Private healthcare invoices slow in 2025: Healthcode

1.6% slowdown in Q3 2025

Cameron Roberts
clock 28 October 2025 • 1 min read
NHS patients receive 6.15m private appointments and tests
PMI

NHS patients receive 6.15m private appointments and tests

"We’re not prepared to continue 2-tier healthcare"

Jaskeet Briah
clock 27 October 2025 • 3 min read
National Friendly launches healthcare product
PMI

National Friendly launches healthcare product

No medical questions or underwriting

Jaskeet Briah
clock 14 October 2025 • 2 min read

Highlights

COVER Survey: Advisers damning of protection insurer service levels

COVER Survey: Advisers damning of protection insurer service levels

"It takes longer than ever to get underwriting terms"

John Brazier
clock 12 October 2023 • 5 min read
Online reviews trump price for young people selecting life and health cover

Online reviews trump price for young people selecting life and health cover

According to latest ReMark report

John Brazier
clock 11 October 2023 • 2 min read
ABI members with staff neurodiversity policy nearly doubles

ABI members with staff neurodiversity policy nearly doubles

Women within executive teams have grown to 32%

Jaskeet Briah
clock 10 October 2023 • 3 min read